Amalia
Lafuente
Publikationen, an denen er mitarbeitet Amalia Lafuente (8)
2020
-
Association study of candidate genes with obesity and metabolic traits in antipsychotic-treated patients with first-episode psychosis over a 2-year period
Journal of Psychopharmacology, Vol. 34, Núm. 5, pp. 514-523
-
Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort
Acta Psychiatrica Scandinavica, Vol. 141, Núm. 6, pp. 541-552
2019
-
Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis
European Neuropsychopharmacology, Vol. 29, Núm. 6, pp. 786-794
2018
-
Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis
Journal of Psychopharmacology, Vol. 32, Núm. 6, pp. 702-710
2017
-
Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients
European Neuropsychopharmacology, Vol. 27, Núm. 7, pp. 647-656
2016
-
A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project
International Journal of Neuropsychopharmacology, Vol. 19, Núm. 4
-
Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: Role of dopamine, serotonin and glutamate candidate genes
Pharmacogenomics Journal, Vol. 16, Núm. 5, pp. 439-445
2014
-
Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: Toward an integrative inflammatory hypothesis of schizophrenia
Schizophrenia Bulletin, Vol. 40, Núm. 2, pp. 376-387